4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma
Clinical trial NCT00818454 · COMPLETED
Trial details
- NCT number
- NCT00818454
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2009-09-01
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.